In this presentation from Glaucoma Subspecialty Day 2022, Dr. Jonathan Myers shares data supporting the use of selective laser trabeculoplasty (SLT) and how he presents SLT to patients as a better option. Specific topics include the following:

• findings from the Glaucoma Laser Trial (GLT), the Laser in Glaucoma and Ocular Hypertension (LiGHT) trial, and other studies
• SLT as the standard of care
• the effectiveness of educational intervention
• patient messaging to support SLT over eyedrops
• assuming that patients will choose SLT